Browse Products by Therapy

Cefazolin Injection, USP, 1 gram/50 mL in GALAXY Plastic Container. Frozen Premix.

Email | Print

SKU: 2G3503

Cefazolin Injection, USP, 1 gram/50 mL, Iso-Osmotic in GALAXY Plastic Container. Frozen Premix. NDC 0338-3503-41

Product information last updated Dec-18-2019

Product Characteristics

Latex: Not Made with Natural Rubber Latex
Container Type: GALAXY
PVC: Non-PVC
DEHP: Non-DEHP
Volume: 50 ML
Drug Class: Anti-Infective
Dosage Form: Frozen
Diluent: Dextrose
Strength: 1 gm/50 mL
Concentration: 20 mg/mL
Shelf Life from manufacture: 24 months
Contains Preservative: No
Storage Recommendations: Store at or below-20°C (-4°F). The thawed solution is stable for 30 days under refrigeration 5°C (41°F) and 48 hours at 25°C (77°F). Do not refreeze.
Rx Only: Yes
Package Insert Link: baxterpi.com/pi-pdf/Cefaz(..)

Carton

Length: 12 IN
Width: 5.8 IN
Height: 3.1 IN
Volume: 0.13 FC
Weight: 3.5 LB
Pack Factor: 24

Website Links

baxterpi.com/pi-pdf/Cefaz(..)
Disclaimer: Baxter Healthcare Corporation does not review or control the content of any non-Baxter site. Baxter Healthcare Corporation does not endorse and is not responsible for the accuracy, content, practices or standards of any non-Baxter sources.

Reimbursement Information

HCPCS Code HCPCS Descriptor
J0690 INJECTION, CEFAZOLIN SODIUM, 500 MG
A4216 STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
Medication Delivery Reimbursement Hotline 888-338-0001
Information Source: CMS
Disclaimer: The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.